dl
YearMonthDate 2014 7 1
format = edgelist1	
n=2000	
data:
standard call 1.0	
tumor patient 1.0	
test subgroup 0.8533916849015317	
test pathologi 0.8533916849015317	
tailor chromosom 1.0	
studi larg 1.0	
networkamayo anaplast 0.8533916849015317	
led genet 0.8533916849015317	
lymphoma alk 0.8533916849015317	
swap lymphoma 1.0	
discov differenti 0.8533916849015317	
clinic anaplast 0.8533916849015317	
type lymphoma 0.8533916849015317	
routin cell 0.8533916849015317	
routin percent 0.8533916849015317	
situhybrid exampl 1.0	
test recommend 1.0	
neg lymphomathat 0.8533916849015317	
fluorescencein abnorm 1.0	
individu fish 1.0	
neg anaplast 0.8533916849015317	
team hadtp 0.8533916849015317	
exampl evalu 1.0	
tailor critic 1.0	
haddusp alcl 0.8533916849015317	
therapi recommend 1.0	
singl percent 0.8533916849015317	
rearrang new 0.8533916849015317	
team routin 0.8533916849015317	
patient alk 0.8533916849015317	
tp identifi 1.0	
lymphoma larg 1.0	
subgroup pathologi 0.8533916849015317	
networkamayo findingsar 0.8533916849015317	
pathologist dna 1.0	
test clinic 0.8533916849015317	
lymphoma aid 0.8533916849015317	
research lymphoma 0.8533916849015317	
test journalblood 0.8533916849015317	
subgroup research 0.8533916849015317	
subgroup larg 0.8533916849015317	
identifi fish 1.0	
type larg 0.8533916849015317	
networkamayo clinic 0.8533916849015317	
differenti aid 0.8533916849015317	
patient aid 0.8533916849015317	
surviv pathologi 0.8533916849015317	
group clinic 0.8533916849015317	
hodgkin cell 0.8533916849015317	
led anaplast 0.8533916849015317	
networkamayo led 0.8533916849015317	
diagnos critic 1.0	
patient larg 0.8533916849015317	
singl lymphomathat 0.8533916849015317	
singl lymphoma 0.8533916849015317	
year lymphoma 0.8533916849015317	
lymphoma clinic 0.8533916849015317	
type hadtp 0.8533916849015317	
live differenti 0.8533916849015317	
percent markedli 0.8533916849015317	
microscop author 1.0	
new genet 0.8533916849015317	
tailor develop 1.0	
journalblood chanc 0.8533916849015317	
singl genet 0.8533916849015317	
subgroup group 0.8533916849015317	
step disturb 1.0	
lymphoma disturb 1.0	
individu genet 1.0	
hadtp group 0.8533916849015317	
ofnon genet 0.8533916849015317	
patient alk 1.0	
rate alcl 0.8533916849015317	
test larg 0.8533916849015317	
microscop cell 1.0	
patient hadtp 0.8533916849015317	
research group 0.8533916849015317	
singl neg 0.8533916849015317	
team clinic 0.8533916849015317	
patient led 0.8533916849015317	
alk alcl 0.8533916849015317	
patient findingsar 0.8533916849015317	
visual tumor 1.0	
therapi step 1.0	
subgroup anaplast 0.8533916849015317	
tumor fluorescencein 1.0	
patient fluorescencein 1.0	
lymphoma exampl 1.0	
type journalblood 0.8533916849015317	
subgroup differenti 0.8533916849015317	
visual abnorm 1.0	
critic cell 1.0	
live findingsar 0.8533916849015317	
patient findingsar 0.8533916849015317	
year percent 0.8533916849015317	
pathologist critic 1.0	
team singl 0.8533916849015317	
percent compar 0.8533916849015317	
patient differenti 0.8533916849015317	
tailor pathologist 1.0	
pathologi haddusp 0.8533916849015317	
publishedin anaplast 0.8533916849015317	
lymphoma clinic 0.8533916849015317	
pathologist diagnos 1.0	
tp tailor 1.0	
fish develop 1.0	
ofnon hodgkin 0.8533916849015317	
markedli haddusp 0.8533916849015317	
patient abnorm 1.0	
disturb author 1.0	
dna abnorm 1.0	
test gene 1.0	
test aid 0.8533916849015317	
journalblood differenti 0.8533916849015317	
tumor hadtp 0.8533916849015317	
surviv group 0.8533916849015317	
patient arrang 1.0	
pathologi lymphomathat 0.8533916849015317	
markedli bymayo 0.8533916849015317	
surviv hodgkin 0.8533916849015317	
routin percent 0.8533916849015317	
rate patient 0.8533916849015317	
cell call 1.0	
year new 0.8533916849015317	
patient compar 0.8533916849015317	
subgroup patient 0.8533916849015317	
situhybrid dna 1.0	
visual lymphoma 1.0	
rearrang develop 1.0	
led clinic 0.8533916849015317	
singl findingsar 0.8533916849015317	
type test 0.8533916849015317	
year team 0.8533916849015317	
tailor fluorescencein 1.0	
dna abnorm 1.0	
recommend identifi 1.0	
diagnosi bymayo 0.8533916849015317	
individu diagnos 1.0	
swap develop 1.0	
lymphomathat chanc 0.8533916849015317	
rearrang networkamayo 0.8533916849015317	
tailor alk 1.0	
pathologist gene 1.0	
diagnosi clinic 0.8533916849015317	
team patient 0.8533916849015317	
networkamayo differenti 0.8533916849015317	
publishedin lymphoma 0.8533916849015317	
subgroup findingsar 0.8533916849015317	
subgroup cell 0.8533916849015317	
neg fluorescencein 1.0	
haddusp group 0.8533916849015317	
publishedin cell 0.8533916849015317	
subgroup research 0.8533916849015317	
pathologist arrang 1.0	
haddusp clinic 0.8533916849015317	
patient neg 0.8533916849015317	
visual gene 1.0	
larg chanc 0.8533916849015317	
larg compar 0.8533916849015317	
swap standard 1.0	
therapi larg 1.0	
group alk 0.8533916849015317	
findingsar chanc 0.8533916849015317	
year differenti 0.8533916849015317	
ofnon neg 0.8533916849015317	
recommend publishedin 0.8533916849015317	
critic arrang 1.0	
identifi develop 1.0	
standard diagnos 1.0	
recommend cell 0.8533916849015317	
identifi critic 1.0	
patient haddusp 0.8533916849015317	
patient journalblood 0.8533916849015317	
rate pathologi 0.8533916849015317	
tumor lymphoma 1.0	
recommend live 0.8533916849015317	
led cell 0.8533916849015317	
rearrang ofnon 0.8533916849015317	
lymphoma diagnos 1.0	
patient abnorm 1.0	
compar alcl 0.8533916849015317	
larg anddusp 1.0	
recommend anaplast 0.8533916849015317	
led larg 0.8533916849015317	
ofnon cell 0.8533916849015317	
therapi rearrang 1.0	
microscop chromosom 1.0	
fish dna 1.0	
networkamayo larg 0.8533916849015317	
percent alcl 0.8533916849015317	
patient diagnosi 0.8533916849015317	
recommend haddusp 0.8533916849015317	
networkamayo markedli 0.8533916849015317	
team subgroup 0.8533916849015317	
test call 1.0	
diagnosi alk 0.8533916849015317	
tumor led 0.8533916849015317	
group aid 0.8533916849015317	
tumor anaplast 1.0	
hadtp clinic 0.8533916849015317	
subgroup alk 0.8533916849015317	
type differenti 0.8533916849015317	
chromosom anaplast 1.0	
surviv rearrang 0.8533916849015317	
rearrang larg 0.8533916849015317	
larg haddusp 0.8533916849015317	
rearrang patient 0.8533916849015317	
rate chanc 0.8533916849015317	
develop call 1.0	
tp test 1.0	
subgroup lymphoma 0.8533916849015317	
test exampl 1.0	
hodgkin anaplast 0.8533916849015317	
new differenti 0.8533916849015317	
patient chanc 0.8533916849015317	
tumor abnorm 1.0	
tumor therapi 1.0	
singl chanc 0.8533916849015317	
patient markedli 0.8533916849015317	
develop chromosom 1.0	
year findingsar 0.8533916849015317	
singl live 0.8533916849015317	
genet anddusp 1.0	
team bymayo 0.8533916849015317	
lymphomathat led 0.8533916849015317	
standard patient 1.0	
singl anaplast 0.8533916849015317	
surviv journalblood 0.8533916849015317	
evalu call 1.0	
patient aid 0.8533916849015317	
publishedin hadtp 0.8533916849015317	
percent ofnon 0.8533916849015317	
dna arrang 1.0	
standard rearrang 1.0	
visual tailor 1.0	
therapi test 1.0	
team new 0.8533916849015317	
subgroup group 0.8533916849015317	
rearrang aid 0.8533916849015317	
singl routin 0.8533916849015317	
therapi fish 1.0	
therapi call 1.0	
test standard 1.0	
test step 1.0	
standard critic 1.0	
markedli differenti 0.8533916849015317	
critic call 1.0	
team anaplast 0.8533916849015317	
rearrang patient 0.8533916849015317	
type publishedin 0.8533916849015317	
larg discov 0.8533916849015317	
rearrang rate 0.8533916849015317	
tumor findingsar 0.8533916849015317	
rate ofnon 0.8533916849015317	
patient neg 0.8533916849015317	
lymphoma identifi 1.0	
swap step 1.0	
networkamayo aid 0.8533916849015317	
larg journalblood 0.8533916849015317	
genet aid 0.8533916849015317	
publishedin journalblood 0.8533916849015317	
percent diagnosi 0.8533916849015317	
percent alk 0.8533916849015317	
rearrang findingsar 0.8533916849015317	
subgroup live 0.8533916849015317	
markedli hadtp 0.8533916849015317	
test findingsar 0.8533916849015317	
studi author 1.0	
subgroup networkamayo 0.8533916849015317	
publishedin clinic 0.8533916849015317	
fish disturb 1.0	
pathologi new 0.8533916849015317	
year diagnosi 0.8533916849015317	
networkamayo genet 0.8533916849015317	
visual genet 1.0	
tumor tp 1.0	
subgroup alcl 0.8533916849015317	
tumor test 0.8533916849015317	
type live 0.8533916849015317	
anaplast alcl 0.8533916849015317	
tp author 1.0	
routin pathologi 0.8533916849015317	
standard genet 1.0	
pathologist lymphoma 1.0	
rearrang findingsar 0.8533916849015317	
patient markedli 0.8533916849015317	
ofnon larg 0.8533916849015317	
patient lymphoma 0.8533916849015317	
step perform 1.0	
research larg 0.8533916849015317	
patient larg 0.8533916849015317	
evalu cell 1.0	
subgroup markedli 0.8533916849015317	
lymphoma diagnos 1.0	
patient genet 0.8533916849015317	
team lymphomathat 0.8533916849015317	
subgroup compar 0.8533916849015317	
lymphoma differenti 0.8533916849015317	
type rate 0.8533916849015317	
chromosom abnorm 1.0	
subgroup neg 0.8533916849015317	
recommend fluorescencein 1.0	
larg fish 1.0	
tailor lymphoma 1.0	
individu fish 1.0	
patient journalblood 0.8533916849015317	
tp individu 1.0	
alk abnorm 1.0	
tumor rearrang 0.8533916849015317	
hodgkin clinic 0.8533916849015317	
cell abnorm 1.0	
tumor differenti 0.8533916849015317	
tailor standard 1.0	
pathologi hadtp 0.8533916849015317	
neg anaplast 1.0	
cell anaplast 0.8533916849015317	
tumor tp 1.0	
rearrang cell 0.8533916849015317	
clinic cell 0.8533916849015317	
recommend patient 0.8533916849015317	
rate networkamayo 0.8533916849015317	
networkamayo cell 0.8533916849015317	
patient genet 0.8533916849015317	
patient markedli 0.8533916849015317	
test markedli 0.8533916849015317	
swap diagnos 1.0	
patient fluorescencein 1.0	
step situhybrid 1.0	
test genet 1.0	
journalblood haddusp 0.8533916849015317	
perform gene 1.0	
rearrang percent 0.8533916849015317	
genet disturb 1.0	
year journalblood 0.8533916849015317	
lymphomathat journalblood 0.8533916849015317	
rearrang chanc 0.8533916849015317	
networkamayo haddusp 0.8533916849015317	
patient alk 0.8533916849015317	
subgroup routin 0.8533916849015317	
patient group 0.8533916849015317	
subgroup hodgkin 0.8533916849015317	
research publishedin 0.8533916849015317	
rate led 0.8533916849015317	
differenti clinic 0.8533916849015317	
subgroup anaplast 0.8533916849015317	
pathologi neg 0.8533916849015317	
research hadtp 0.8533916849015317	
tumor journalblood 0.8533916849015317	
live led 0.8533916849015317	
pathologist lymphoma 1.0	
live journalblood 0.8533916849015317	
percent lymphomathat 0.8533916849015317	
fish chromosom 1.0	
diagnos arrang 1.0	
year patient 0.8533916849015317	
rearrang diagnosi 0.8533916849015317	
visual fluorescencein 1.0	
routin chanc 0.8533916849015317	
step standard 1.0	
rearrang aid 0.8533916849015317	
tumor studi 1.0	
publishedin alk 0.8533916849015317	
tumor group 0.8533916849015317	
subgroup lymphoma 0.8533916849015317	
hadtp cell 0.8533916849015317	
cell abnorm 1.0	
led differenti 0.8533916849015317	
test compar 0.8533916849015317	
led chanc 0.8533916849015317	
recommend networkamayo 0.8533916849015317	
surviv percent 0.8533916849015317	
genet abnorm 1.0	
year type 0.8533916849015317	
larg clinic 0.8533916849015317	
discov cell 0.8533916849015317	
tumor microscop 1.0	
tp test 1.0	
rate genet 0.8533916849015317	
patient chanc 0.8533916849015317	
test new 0.8533916849015317	
publishedin patient 0.8533916849015317	
patient lymphoma 0.8533916849015317	
publishedin patient 0.8533916849015317	
team hodgkin 0.8533916849015317	
pathologist develop 1.0	
publishedin patient 0.8533916849015317	
recommend cell 1.0	
situhybrid identifi 1.0	
year live 0.8533916849015317	
rearrang patient 1.0	
genet fluorescencein 1.0	
discov aid 0.8533916849015317	
neg haddusp 0.8533916849015317	
led compar 0.8533916849015317	
year genet 0.8533916849015317	
rate patient 0.8533916849015317	
patient lymphoma 0.8533916849015317	
step evalu 1.0	
hodgkin alcl 0.8533916849015317	
alk aid 0.8533916849015317	
lymphoma findingsar 0.8533916849015317	
percent journalblood 0.8533916849015317	
standard dna 1.0	
percent patient 0.8533916849015317	
rearrang genet 0.8533916849015317	
rate aid 0.8533916849015317	
tumor patient 0.8533916849015317	
lymphoma develop 1.0	
group chanc 0.8533916849015317	
networkamayo lymphomathat 0.8533916849015317	
ofnon clinic 0.8533916849015317	
routin anaplast 0.8533916849015317	
fish call 1.0	
live genet 0.8533916849015317	
situhybrid genet 1.0	
type group 0.8533916849015317	
rate anaplast 0.8533916849015317	
tp abnorm 1.0	
fish dna 1.0	
individu cell 1.0	
markedli aid 0.8533916849015317	
type diagnosi 0.8533916849015317	
recommend lymphoma 0.8533916849015317	
larg hodgkin 0.8533916849015317	
tumor discov 0.8533916849015317	
lymphoma larg 1.0	
new hodgkin 0.8533916849015317	
networkamayo journalblood 0.8533916849015317	
patient anaplast 1.0	
rearrang lymphoma 0.8533916849015317	
percent networkamayo 0.8533916849015317	
subgroup singl 0.8533916849015317	
therapi fluorescencein 1.0	
hodgkin aid 0.8533916849015317	
singl led 0.8533916849015317	
recommend rearrang 0.8533916849015317	
tumor surviv 0.8533916849015317	
rate hadtp 0.8533916849015317	
patient discov 0.8533916849015317	
lymphomathat cell 0.8533916849015317	
rearrang live 0.8533916849015317	
situhybrid fish 1.0	
percent networkamayo 0.8533916849015317	
clinic bymayo 0.8533916849015317	
markedli discov 0.8533916849015317	
percent patient 0.8533916849015317	
year cell 0.8533916849015317	
neg chanc 0.8533916849015317	
tumor studi 1.0	
team publishedin 0.8533916849015317	
lymphoma alk 1.0	
type bymayo 0.8533916849015317	
rearrang lymphoma 0.8533916849015317	
larg diagnosi 0.8533916849015317	
research patient 0.8533916849015317	
subgroup aid 0.8533916849015317	
new journalblood 0.8533916849015317	
patient new 0.8533916849015317	
pathologi ofnon 0.8533916849015317	
haddusp differenti 0.8533916849015317	
test patient 1.0	
test recommend 0.8533916849015317	
percent genet 0.8533916849015317	
neg cell 0.8533916849015317	
test rearrang 0.8533916849015317	
type patient 0.8533916849015317	
fish exampl 1.0	
live cell 0.8533916849015317	
fish cell 1.0	
exampl abnorm 1.0	
type subgroup 0.8533916849015317	
clinic cell 0.8533916849015317	
patient chanc 0.8533916849015317	
pathologi lymphoma 0.8533916849015317	
genet bymayo 0.8533916849015317	
lymphoma group 0.8533916849015317	
disturb cell 1.0	
standard microscop 1.0	
percent lymphoma 0.8533916849015317	
ofnon lymphoma 0.8533916849015317	
fish alk 1.0	
step arrang 1.0	
haddusp discov 0.8533916849015317	
rearrang pathologi 0.8533916849015317	
test subgroup 0.8533916849015317	
led haddusp 0.8533916849015317	
tumor call 1.0	
lymphoma cell 1.0	
studi exampl 1.0	
rate haddusp 0.8533916849015317	
subgroup ofnon 0.8533916849015317	
patient alk 0.8533916849015317	
patient led 0.8533916849015317	
year led 0.8533916849015317	
subgroup clinic 0.8533916849015317	
rate differenti 0.8533916849015317	
recommend percent 0.8533916849015317	
new hadtp 0.8533916849015317	
diagnos abnorm 1.0	
test hodgkin 0.8533916849015317	
rearrang patient 0.8533916849015317	
patient larg 0.8533916849015317	
networkamayo live 0.8533916849015317	
test evalu 1.0	
year compar 0.8533916849015317	
markedli larg 0.8533916849015317	
patient networkamayo 0.8533916849015317	
tumor standard 1.0	
year rearrang 0.8533916849015317	
patient compar 0.8533916849015317	
patient call 1.0	
patient anaplast 0.8533916849015317	
neg group 0.8533916849015317	
rearrang patient 0.8533916849015317	
research ofnon 0.8533916849015317	
recommend clinic 0.8533916849015317	
research neg 0.8533916849015317	
pathologist genet 1.0	
routin lymphoma 0.8533916849015317	
patient networkamayo 0.8533916849015317	
lymphomathat differenti 0.8533916849015317	
lymphomathat aid 0.8533916849015317	
patient cell 1.0	
fluorescencein critic 1.0	
subgroup rate 0.8533916849015317	
test evalu 1.0	
lymphoma diagnosi 0.8533916849015317	
recommend hodgkin 0.8533916849015317	
fish exampl 1.0	
lymphoma abnorm 1.0	
hodgkin bymayo 0.8533916849015317	
lymphomathat compar 0.8533916849015317	
dna anddusp 1.0	
rearrang new 0.8533916849015317	
routin group 0.8533916849015317	
neg bymayo 0.8533916849015317	
lymphoma clinic 0.8533916849015317	
research findingsar 0.8533916849015317	
routin hodgkin 0.8533916849015317	
swap identifi 1.0	
perform fish 1.0	
dna diagnos 1.0	
type percent 0.8533916849015317	
test rearrang 1.0	
live chanc 0.8533916849015317	
percent led 0.8533916849015317	
visual situhybrid 1.0	
journalblood alk 0.8533916849015317	
tumor disturb 1.0	
recommend call 1.0	
rearrang publishedin 0.8533916849015317	
research lymphomathat 0.8533916849015317	
hodgkin clinic 0.8533916849015317	
larg genet 1.0	
microscop fluorescencein 1.0	
lymphoma cell 0.8533916849015317	
percent lymphomathat 0.8533916849015317	
tumor alk 1.0	
critic abnorm 1.0	
rearrang discov 0.8533916849015317	
visual anddusp 1.0	
routin ofnon 0.8533916849015317	
test anddusp 1.0	
studi abnorm 1.0	
patient differenti 0.8533916849015317	
subgroup haddusp 0.8533916849015317	
team alcl 0.8533916849015317	
swap perform 1.0	
compar clinic 0.8533916849015317	
group anaplast 0.8533916849015317	
singl clinic 0.8533916849015317	
year anaplast 0.8533916849015317	
tumor cell 0.8533916849015317	
new larg 0.8533916849015317	
test bymayo 0.8533916849015317	
rearrang networkamayo 0.8533916849015317	
lymphoma led 0.8533916849015317	
pathologi aid 0.8533916849015317	
lymphoma bymayo 0.8533916849015317	
surviv rearrang 0.8533916849015317	
type genet 0.8533916849015317	
situhybrid cell 1.0	
fish abnorm 1.0	
ofnon led 0.8533916849015317	
microscop fish 1.0	
team lymphoma 0.8533916849015317	
tp chromosom 1.0	
patient clinic 0.8533916849015317	
led hodgkin 0.8533916849015317	
patient genet 1.0	
publishedin clinic 0.8533916849015317	
studi dna 1.0	
lymphoma disturb 1.0	
patient new 0.8533916849015317	
subgroup patient 0.8533916849015317	
diagnosi aid 0.8533916849015317	
studi patient 1.0	
test percent 0.8533916849015317	
surviv bymayo 0.8533916849015317	
genet alk 0.8533916849015317	
routin rearrang 0.8533916849015317	
type tumor 0.8533916849015317	
rate lymphoma 0.8533916849015317	
surviv lymphomathat 0.8533916849015317	
tp recommend 1.0	
ofnon networkamayo 0.8533916849015317	
team patient 0.8533916849015317	
findingsar alk 0.8533916849015317	
journalblood group 0.8533916849015317	
hodgkin group 0.8533916849015317	
markedli compar 0.8533916849015317	
routin hadtp 0.8533916849015317	
dna alk 1.0	
group findingsar 0.8533916849015317	
recommend led 0.8533916849015317	
recommend ofnon 0.8533916849015317	
rearrang patient 0.8533916849015317	
microscop arrang 1.0	
rate larg 0.8533916849015317	
journalblood findingsar 0.8533916849015317	
research alk 0.8533916849015317	
team rearrang 0.8533916849015317	
tumor cell 1.0	
swap alk 1.0	
surviv recommend 0.8533916849015317	
pathologi diagnosi 0.8533916849015317	
anddusp alk 1.0	
visual abnorm 1.0	
alcl aid 0.8533916849015317	
surviv neg 0.8533916849015317	
patient lymphoma 1.0	
haddusp anaplast 0.8533916849015317	
individu abnorm 1.0	
tumor new 0.8533916849015317	
new compar 0.8533916849015317	
genet findingsar 0.8533916849015317	
tumor cell 1.0	
group diagnosi 0.8533916849015317	
tumor publishedin 0.8533916849015317	
visual call 1.0	
routin alk 0.8533916849015317	
routin live 0.8533916849015317	
test clinic 0.8533916849015317	
patient chromosom 1.0	
compar cell 0.8533916849015317	
ofnon live 0.8533916849015317	
therapi fish 1.0	
patient cell 0.8533916849015317	
tumor patient 0.8533916849015317	
tumor cell 1.0	
test lymphoma 0.8533916849015317	
call abnorm 1.0	
type alcl 0.8533916849015317	
patient anaplast 0.8533916849015317	
therapi test 1.0	
surviv subgroup 0.8533916849015317	
lymphomathat hadtp 0.8533916849015317	
fish abnorm 1.0	
percent aid 0.8533916849015317	
rearrang diagnosi 0.8533916849015317	
test pathologist 1.0	
new anaplast 0.8533916849015317	
ofnon chanc 0.8533916849015317	
genet cell 1.0	
rearrang markedli 0.8533916849015317	
year subgroup 0.8533916849015317	
standard neg 1.0	
patient pathologi 0.8533916849015317	
recommend differenti 0.8533916849015317	
group clinic 0.8533916849015317	
larg findingsar 0.8533916849015317	
subgroup larg 0.8533916849015317	
journalblood compar 0.8533916849015317	
type aid 0.8533916849015317	
visual evalu 1.0	
new lymphoma 0.8533916849015317	
type rearrang 0.8533916849015317	
subgroup hadtp 0.8533916849015317	
larg fish 1.0	
identifi author 1.0	
year group 0.8533916849015317	
lymphoma critic 1.0	
rearrang patient 0.8533916849015317	
dna cell 1.0	
lymphoma anaplast 0.8533916849015317	
subgroup cell 0.8533916849015317	
situhybrid patient 1.0	
year lymphoma 0.8533916849015317	
routin networkamayo 0.8533916849015317	
anaplast alk 0.8533916849015317	
research aid 0.8533916849015317	
team diagnosi 0.8533916849015317	
surviv lymphoma 0.8533916849015317	
research lymphoma 0.8533916849015317	
percent genet 0.8533916849015317	
test alk 1.0	
differenti cell 0.8533916849015317	
therapi identifi 1.0	
neg alk 1.0	
haddusp diagnosi 0.8533916849015317	
routin haddusp 0.8533916849015317	
tumor markedli 0.8533916849015317	
live group 0.8533916849015317	
findingsar anaplast 0.8533916849015317	
year chanc 0.8533916849015317	
surviv ofnon 0.8533916849015317	
fluorescencein call 1.0	
surviv clinic 0.8533916849015317	
dna author 1.0	
critic anddusp 1.0	
percent clinic 0.8533916849015317	
test networkamayo 0.8533916849015317	
step fish 1.0	
visual individu 1.0	
tp critic 1.0	
perform critic 1.0	
rate patient 0.8533916849015317	
therapi dna 1.0	
neg diagnos 1.0	
disturb diagnos 1.0	
rate discov 0.8533916849015317	
tp anaplast 1.0	
markedli anaplast 0.8533916849015317	
team markedli 0.8533916849015317	
percent led 0.8533916849015317	
surviv singl 0.8533916849015317	
markedli cell 0.8533916849015317	
neg diagnosi 0.8533916849015317	
patient gene 1.0	
fluorescencein diagnos 1.0	
percent differenti 0.8533916849015317	
pathologi alcl 0.8533916849015317	
surviv hadtp 0.8533916849015317	
identifi fluorescencein 1.0	
tumor abnorm 1.0	
journalblood hadtp 0.8533916849015317	
test anaplast 0.8533916849015317	
fish arrang 1.0	
hadtp chanc 0.8533916849015317	
subgroup publishedin 0.8533916849015317	
subgroup chanc 0.8533916849015317	
recommend aid 0.8533916849015317	
tumor patient 0.8533916849015317	
surviv diagnosi 0.8533916849015317	
tumor identifi 1.0	
type rearrang 0.8533916849015317	
lymphoma haddusp 0.8533916849015317	
ofnon alcl 0.8533916849015317	
perform cell 1.0	
bymayo aid 0.8533916849015317	
situhybrid evalu 1.0	
patient fish 1.0	
visual perform 1.0	
test neg 1.0	
rearrang pathologi 0.8533916849015317	
lymphoma journalblood 0.8533916849015317	
rate bymayo 0.8533916849015317	
test disturb 1.0	
subgroup ofnon 0.8533916849015317	
year subgroup 0.8533916849015317	
diagnos anaplast 1.0	
surviv findingsar 0.8533916849015317	
test lymphoma 0.8533916849015317	
step diagnos 1.0	
tumor clinic 0.8533916849015317	
new clinic 0.8533916849015317	
therapi lymphoma 1.0	
exampl cell 1.0	
tp patient 1.0	
genet compar 0.8533916849015317	
develop abnorm 1.0	
patient cell 1.0	
subgroup rearrang 0.8533916849015317	
subgroup routin 0.8533916849015317	
tumor lymphoma 0.8533916849015317	
patient networkamayo 0.8533916849015317	
recommend alk 0.8533916849015317	
test routin 0.8533916849015317	
markedli findingsar 0.8533916849015317	
journalblood genet 0.8533916849015317	
research new 0.8533916849015317	
team aid 0.8533916849015317	
rearrang anaplast 0.8533916849015317	
year alcl 0.8533916849015317	
year bymayo 0.8533916849015317	
subgroup rate 0.8533916849015317	
genet fish 1.0	
lymphoma anaplast 1.0	
rearrang live 0.8533916849015317	
rate clinic 0.8533916849015317	
lymphomathat anaplast 0.8533916849015317	
patient findingsar 0.8533916849015317	
research haddusp 0.8533916849015317	
test lymphoma 1.0	
neg evalu 1.0	
neg alk 0.8533916849015317	
swap patient 1.0	
patient diagnosi 0.8533916849015317	
test led 0.8533916849015317	
year haddusp 0.8533916849015317	
patient differenti 0.8533916849015317	
patient author 1.0	
diagnos abnorm 1.0	
tumor swap 1.0	
rearrang abnorm 1.0	
year tumor 0.8533916849015317	
lymphoma abnorm 1.0	
year neg 0.8533916849015317	
step alk 1.0	
research discov 0.8533916849015317	
test singl 0.8533916849015317	
lymphoma fish 1.0	
new live 0.8533916849015317	
surviv chanc 0.8533916849015317	
hodgkin alk 0.8533916849015317	
year research 0.8533916849015317	
routin neg 0.8533916849015317	
genet clinic 0.8533916849015317	
led hadtp 0.8533916849015317	
tumor step 1.0	
hodgkin discov 0.8533916849015317	
markedli journalblood 0.8533916849015317	
patient lymphoma 1.0	
test chromosom 1.0	
test arrang 1.0	
tailor author 1.0	
tumor lymphoma 0.8533916849015317	
lymphoma cell 1.0	
year percent 0.8533916849015317	
rearrang clinic 0.8533916849015317	
percent markedli 0.8533916849015317	
neg call 1.0	
tumor fish 1.0	
neg findingsar 0.8533916849015317	
lymphoma hodgkin 0.8533916849015317	
visual microscop 1.0	
team rearrang 0.8533916849015317	
gene develop 1.0	
led alk 0.8533916849015317	
lymphoma larg 0.8533916849015317	
lymphoma compar 0.8533916849015317	
research genet 0.8533916849015317	
live diagnosi 0.8533916849015317	
tumor test 1.0	
publishedin hodgkin 0.8533916849015317	
percent clinic 0.8533916849015317	
singl diagnosi 0.8533916849015317	
test abnorm 1.0	
compar alk 0.8533916849015317	
percent live 0.8533916849015317	
author arrang 1.0	
test haddusp 0.8533916849015317	
rearrang lymphoma 1.0	
discov alcl 0.8533916849015317	
type anaplast 0.8533916849015317	
led diagnosi 0.8533916849015317	
percent new 0.8533916849015317	
year larg 0.8533916849015317	
surviv alcl 0.8533916849015317	
publishedin findingsar 0.8533916849015317	
surviv patient 0.8533916849015317	
pathologist abnorm 1.0	
networkamayo lymphoma 0.8533916849015317	
routin journalblood 0.8533916849015317	
larg cell 0.8533916849015317	
routin clinic 0.8533916849015317	
percent compar 0.8533916849015317	
research diagnosi 0.8533916849015317	
anaplast abnorm 1.0	
microscop dna 1.0	
pathologi clinic 0.8533916849015317	
type compar 0.8533916849015317	
swap larg 1.0	
lymphoma individu 1.0	
subgroup journalblood 0.8533916849015317	
singl alcl 0.8533916849015317	
team haddusp 0.8533916849015317	
routin patient 0.8533916849015317	
dna critic 1.0	
test chromosom 1.0	
patient discov 0.8533916849015317	
test neg 1.0	
year clinic 0.8533916849015317	
chanc bymayo 0.8533916849015317	
haddusp clinic 0.8533916849015317	
studi arrang 1.0	
standard cell 1.0	
routin patient 0.8533916849015317	
publishedin neg 0.8533916849015317	
live hadtp 0.8533916849015317	
neg journalblood 0.8533916849015317	
lymphomathat findingsar 0.8533916849015317	
neg hadtp 0.8533916849015317	
patient hadtp 0.8533916849015317	
rate cell 0.8533916849015317	
studi perform 1.0	
develop abnorm 1.0	
step cell 1.0	
neg fish 1.0	
subgroup recommend 0.8533916849015317	
research anaplast 0.8533916849015317	
lymphomathat discov 0.8533916849015317	
lymphomathat clinic 0.8533916849015317	
publishedin ofnon 0.8533916849015317	
percent clinic 0.8533916849015317	
tumor gene 1.0	
rearrang publishedin 0.8533916849015317	
tp therapi 1.0	
visual patient 1.0	
tailor abnorm 1.0	
arrang alk 1.0	
tumor research 0.8533916849015317	
perform individu 1.0	
recommend rearrang 0.8533916849015317	
routin research 0.8533916849015317	
lymphoma alcl 0.8533916849015317	
tp perform 1.0	
visual alk 1.0	
swap situhybrid 1.0	
tumor clinic 0.8533916849015317	
patient alcl 0.8533916849015317	
tp disturb 1.0	
tumor lymphomathat 0.8533916849015317	
type patient 0.8533916849015317	
networkamayo lymphoma 0.8533916849015317	
led findingsar 0.8533916849015317	
journalblood clinic 0.8533916849015317	
genet cell 0.8533916849015317	
tumor test 1.0	
recommend lymphoma 0.8533916849015317	
hodgkin genet 0.8533916849015317	
rearrang bymayo 0.8533916849015317	
rate markedli 0.8533916849015317	
therapi patient 1.0	
rearrang cell 0.8533916849015317	
publishedin percent 0.8533916849015317	
findingsar bymayo 0.8533916849015317	
lymphoma compar 0.8533916849015317	
team rate 0.8533916849015317	
surviv larg 0.8533916849015317	
surviv genet 0.8533916849015317	
tailor rearrang 1.0	
surviv networkamayo 0.8533916849015317	
new group 0.8533916849015317	
neg clinic 0.8533916849015317	
perform neg 1.0	
research cell 0.8533916849015317	
test percent 0.8533916849015317	
tp call 1.0	
lymphoma genet 0.8533916849015317	
recommend percent 0.8533916849015317	
test fluorescencein 1.0	
pathologist disturb 1.0	
surviv percent 0.8533916849015317	
tp cell 1.0	
publishedin group 0.8533916849015317	
patient clinic 0.8533916849015317	
patient bymayo 0.8533916849015317	
percent haddusp 0.8533916849015317	
step rearrang 1.0	
test lymphomathat 0.8533916849015317	
tailor neg 1.0	
test diagnosi 0.8533916849015317	
singl group 0.8533916849015317	
rate alk 0.8533916849015317	
publishedin networkamayo 0.8533916849015317	
percent lymphoma 0.8533916849015317	
test microscop 1.0	
recommend pathologi 0.8533916849015317	
larg clinic 0.8533916849015317	
genet call 1.0	
research percent 0.8533916849015317	
routin markedli 0.8533916849015317	
rearrang group 0.8533916849015317	
subgroup rearrang 0.8533916849015317	
tumor pathologist 1.0	
clinic chanc 0.8533916849015317	
dna call 1.0	
author anaplast 1.0	
year surviv 0.8533916849015317	
patient hodgkin 0.8533916849015317	
subgroup alcl 0.8533916849015317	
tumor rearrang 0.8533916849015317	
type lymphomathat 0.8533916849015317	
pathologi larg 0.8533916849015317	
recommend chromosom 1.0	
recommend group 0.8533916849015317	
rate neg 0.8533916849015317	
lymphoma hadtp 0.8533916849015317	
research patient 0.8533916849015317	
therapi exampl 1.0	
larg hadtp 0.8533916849015317	
routin compar 0.8533916849015317	
networkamayo alk 0.8533916849015317	
subgroup discov 0.8533916849015317	
percent cell 0.8533916849015317	
cell alk 0.8533916849015317	
larg alcl 0.8533916849015317	
test studi 1.0	
rearrang journalblood 0.8533916849015317	
percent larg 0.8533916849015317	
patient pathologi 0.8533916849015317	
rearrang neg 0.8533916849015317	
microscop develop 1.0	
year discov 0.8533916849015317	
tumor bymayo 0.8533916849015317	
led journalblood 0.8533916849015317	
pathologist fish 1.0	
journalblood aid 0.8533916849015317	
patient dna 1.0	
percent chanc 0.8533916849015317	
recommend findingsar 0.8533916849015317	
hadtp alcl 0.8533916849015317	
team networkamayo 0.8533916849015317	
singl rearrang 0.8533916849015317	
surviv patient 0.8533916849015317	
rearrang microscop 1.0	
step chromosom 1.0	
new bymayo 0.8533916849015317	
microscop disturb 1.0	
networkamayo clinic 0.8533916849015317	
ofnon compar 0.8533916849015317	
singl aid 0.8533916849015317	
step lymphoma 1.0	
routin aid 0.8533916849015317	
publishedin led 0.8533916849015317	
step microscop 1.0	
rearrang alk 0.8533916849015317	
tumor live 0.8533916849015317	
tumor alcl 0.8533916849015317	
type markedli 0.8533916849015317	
rate new 0.8533916849015317	
recommend abnorm 1.0	
tumor dna 1.0	
markedli diagnosi 0.8533916849015317	
visual patient 1.0	
ofnon clinic 0.8533916849015317	
microscop evalu 1.0	
networkamayo neg 0.8533916849015317	
rearrang alcl 0.8533916849015317	
identifi anddusp 1.0	
swap dna 1.0	
clinic aid 0.8533916849015317	
live bymayo 0.8533916849015317	
new diagnosi 0.8533916849015317	
differenti alcl 0.8533916849015317	
rate diagnosi 0.8533916849015317	
recommend develop 1.0	
team findingsar 0.8533916849015317	
identifi cell 1.0	
lymphoma critic 1.0	
subgroup genet 0.8533916849015317	
patient clinic 0.8533916849015317	
hadtp differenti 0.8533916849015317	
genet differenti 0.8533916849015317	
compar aid 0.8533916849015317	
year singl 0.8533916849015317	
type clinic 0.8533916849015317	
step abnorm 1.0	
percent hadtp 0.8533916849015317	
year patient 0.8533916849015317	
clinic alk 0.8533916849015317	
develop cell 1.0	
findingsar aid 0.8533916849015317	
pathologi bymayo 0.8533916849015317	
research hodgkin 0.8533916849015317	
research pathologi 0.8533916849015317	
type alk 0.8533916849015317	
ofnon discov 0.8533916849015317	
subgroup patient 0.8533916849015317	
live hodgkin 0.8533916849015317	
subgroup new 0.8533916849015317	
hadtp findingsar 0.8533916849015317	
identifi call 1.0	
identifi evalu 1.0	
year test 0.8533916849015317	
genet diagnosi 0.8533916849015317	
genet dna 1.0	
recommend compar 0.8533916849015317	
rearrang ofnon 0.8533916849015317	
tumor anaplast 0.8533916849015317	
differenti bymayo 0.8533916849015317	
markedli group 0.8533916849015317	
ofnon haddusp 0.8533916849015317	
discov diagnosi 0.8533916849015317	
networkamayo compar 0.8533916849015317	
critic cell 1.0	
routin rearrang 0.8533916849015317	
lymphoma alk 0.8533916849015317	
neg fish 1.0	
fluorescencein cell 1.0	
patient neg 1.0	
surviv lymphoma 0.8533916849015317	
identifi disturb 1.0	
singl new 0.8533916849015317	
routin discov 0.8533916849015317	
subgroup hodgkin 0.8533916849015317	
tumor fish 1.0	
percent hodgkin 0.8533916849015317	
pathologi clinic 0.8533916849015317	
subgroup differenti 0.8533916849015317	
test live 0.8533916849015317	
surviv new 0.8533916849015317	
tumor exampl 1.0	
recommend evalu 1.0	
patient arrang 1.0	
research live 0.8533916849015317	
rearrang fish 1.0	
lymphoma differenti 0.8533916849015317	
studi lymphoma 1.0	
test rearrang 1.0	
fish abnorm 1.0	
lymphoma fish 1.0	
group genet 0.8533916849015317	
rate lymphomathat 0.8533916849015317	
differenti clinic 0.8533916849015317	
situhybrid lymphoma 1.0	
team genet 0.8533916849015317	
test author 1.0	
individu gene 1.0	
recommend lymphomathat 0.8533916849015317	
subgroup new 0.8533916849015317	
research clinic 0.8533916849015317	
team surviv 0.8533916849015317	
studi neg 1.0	
tumor tailor 1.0	
fish diagnos 1.0	
new cell 0.8533916849015317	
recommend journalblood 0.8533916849015317	
lymphoma call 1.0	
tumor diagnosi 0.8533916849015317	
rearrang bymayo 0.8533916849015317	
singl pathologi 0.8533916849015317	
lymphoma larg 0.8533916849015317	
rearrang disturb 1.0	
research rate 0.8533916849015317	
type percent 0.8533916849015317	
clinic chanc 0.8533916849015317	
live anaplast 0.8533916849015317	
singl rate 0.8533916849015317	
discov clinic 0.8533916849015317	
tp lymphoma 1.0	
tumor aid 0.8533916849015317	
patient lymphomathat 0.8533916849015317	
tp genet 1.0	
lymphoma discov 0.8533916849015317	
chromosom author 1.0	
percent bymayo 0.8533916849015317	
publishedin bymayo 0.8533916849015317	
markedli alk 0.8533916849015317	
subgroup led 0.8533916849015317	
therapi abnorm 1.0	
singl research 0.8533916849015317	
tumor hodgkin 0.8533916849015317	
test ofnon 0.8533916849015317	
tailor patient 1.0	
research rearrang 0.8533916849015317	
patient neg 1.0	
lymphomathat genet 0.8533916849015317	
pathologi live 0.8533916849015317	
rearrang alk 1.0	
tumor perform 1.0	
diagnos chromosom 1.0	
step genet 1.0	
research differenti 0.8533916849015317	
swap anaplast 1.0	
individu abnorm 1.0	
patient haddusp 0.8533916849015317	
diagnos cell 1.0	
rearrang lymphomathat 0.8533916849015317	
team differenti 0.8533916849015317	
routin alcl 0.8533916849015317	
rearrang discov 0.8533916849015317	
identifi genet 1.0	
percent ofnon 0.8533916849015317	
pathologi hodgkin 0.8533916849015317	
studi gene 1.0	
percent patient 0.8533916849015317	
lymphoma discov 0.8533916849015317	
surviv publishedin 0.8533916849015317	
team patient 0.8533916849015317	
surviv live 0.8533916849015317	
recommend individu 1.0	
disturb anaplast 1.0	
fish critic 1.0	
research clinic 0.8533916849015317	
rearrang genet 0.8533916849015317	
lymphoma chanc 0.8533916849015317	
patient clinic 0.8533916849015317	
subgroup diagnosi 0.8533916849015317	
rearrang hadtp 0.8533916849015317	
percent clinic 0.8533916849015317	
year publishedin 0.8533916849015317	
fish evalu 1.0	
gene evalu 1.0	
rate percent 0.8533916849015317	
chromosom alk 1.0	
patient pathologi 0.8533916849015317	
ofnon hadtp 0.8533916849015317	
larg fluorescencein 1.0	
research patient 0.8533916849015317	
tp studi 1.0	
patient evalu 1.0	
live alcl 0.8533916849015317	
percent differenti 0.8533916849015317	
patient led 0.8533916849015317	
rearrang pathologist 1.0	
singl cell 0.8533916849015317	
visual anaplast 1.0	
new networkamayo 0.8533916849015317	
gene exampl 1.0	
situhybrid perform 1.0	
studi step 1.0	
research networkamayo 0.8533916849015317	
clinic bymayo 0.8533916849015317	
bymayo anaplast 0.8533916849015317	
year rearrang 0.8533916849015317	
tumor compar 0.8533916849015317	
lymphomathat live 0.8533916849015317	
routin larg 0.8533916849015317	
publishedin new 0.8533916849015317	
recommend lymphoma 1.0	
live clinic 0.8533916849015317	
hadtp aid 0.8533916849015317	
rate journalblood 0.8533916849015317	
rate lymphoma 0.8533916849015317	
singl clinic 0.8533916849015317	
pathologi differenti 0.8533916849015317	
discov compar 0.8533916849015317	
fish develop 1.0	
patient group 0.8533916849015317	
tailor recommend 1.0	
networkamayo hodgkin 0.8533916849015317	
exampl alk 1.0	
routin lymphomathat 0.8533916849015317	
percent pathologi 0.8533916849015317	
visual dna 1.0	
neg differenti 0.8533916849015317	
team compar 0.8533916849015317	
markedli alcl 0.8533916849015317	
subgroup compar 0.8533916849015317	
genet clinic 0.8533916849015317	
tumor critic 1.0	
evalu anddusp 1.0	
step fish 1.0	
type lymphoma 0.8533916849015317	
percent patient 0.8533916849015317	
singl markedli 0.8533916849015317	
rate live 0.8533916849015317	
rearrang percent 0.8533916849015317	
type haddusp 0.8533916849015317	
ofnon journalblood 0.8533916849015317	
networkamayo diagnosi 0.8533916849015317	
subgroup singl 0.8533916849015317	
research percent 0.8533916849015317	
haddusp alk 0.8533916849015317	
evalu cell 1.0	
patient critic 1.0	
rearrang chanc 0.8533916849015317	
subgroup journalblood 0.8533916849015317	
subgroup genet 0.8533916849015317	
routin diagnosi 0.8533916849015317	
test exampl 1.0	
surviv clinic 0.8533916849015317	
team journalblood 0.8533916849015317	
test team 0.8533916849015317	
patient lymphomathat 0.8533916849015317	
perform call 1.0	
tumor subgroup 0.8533916849015317	
new findingsar 0.8533916849015317	
type recommend 0.8533916849015317	
rearrang lymphoma 0.8533916849015317	
perform anddusp 1.0	
percent new 0.8533916849015317	
lymphoma fluorescencein 1.0	
recommend diagnosi 0.8533916849015317	
tumor genet 0.8533916849015317	
singl lymphoma 0.8533916849015317	
therapi pathologist 1.0	
fish author 1.0	
tumor routin 0.8533916849015317	
genet chanc 0.8533916849015317	
lymphomathat lymphoma 0.8533916849015317	
year lymphomathat 0.8533916849015317	
lymphoma findingsar 0.8533916849015317	
percent neg 0.8533916849015317	
year clinic 0.8533916849015317	
cell alk 1.0	
patient alk 1.0	
rearrang larg 0.8533916849015317	
lymphomathat hodgkin 0.8533916849015317	
patient ofnon 0.8533916849015317	
findingsar compar 0.8533916849015317	
patient group 0.8533916849015317	
networkamayo group 0.8533916849015317	
situhybrid gene 1.0	
routin led 0.8533916849015317	
gene anaplast 1.0	
test abnorm 1.0	
findingsar clinic 0.8533916849015317	
networkamayo bymayo 0.8533916849015317	
neg aid 0.8533916849015317	
rearrang exampl 1.0	
new lymphomathat 0.8533916849015317	
surviv patient 0.8533916849015317	
compar anaplast 0.8533916849015317	
live compar 0.8533916849015317	
routin publishedin 0.8533916849015317	
research journalblood 0.8533916849015317	
lymphomathat bymayo 0.8533916849015317	
markedli hodgkin 0.8533916849015317	
rearrang differenti 0.8533916849015317	
percent hodgkin 0.8533916849015317	
research recommend 0.8533916849015317	
recommend neg 0.8533916849015317	
subgroup percent 0.8533916849015317	
singl hodgkin 0.8533916849015317	
test fish 1.0	
lymphomathat lymphoma 0.8533916849015317	
markedli lymphoma 0.8533916849015317	
live discov 0.8533916849015317	
networkamayo discov 0.8533916849015317	
patient cell 0.8533916849015317	
lymphoma live 0.8533916849015317	
tumor larg 0.8533916849015317	
singl hadtp 0.8533916849015317	
patient clinic 0.8533916849015317	
patient diagnos 1.0	
percent aid 0.8533916849015317	
tumor diagnos 1.0	
discov chanc 0.8533916849015317	
tumor ofnon 0.8533916849015317	
tumor neg 0.8533916849015317	
lymphoma fluorescencein 1.0	
group cell 0.8533916849015317	
percent findingsar 0.8533916849015317	
rearrang markedli 0.8533916849015317	
therapi cell 1.0	
perform evalu 1.0	
type team 0.8533916849015317	
hadtp discov 0.8533916849015317	
test identifi 1.0	
anaplast abnorm 1.0	
year aid 0.8533916849015317	
journalblood cell 0.8533916849015317	
led clinic 0.8533916849015317	
neg cell 1.0	
type clinic 0.8533916849015317	
genet anaplast 0.8533916849015317	
chanc cell 0.8533916849015317	
identifi anaplast 1.0	
fish critic 1.0	
patient hadtp 0.8533916849015317	
tumor percent 0.8533916849015317	
percent live 0.8533916849015317	
neg individu 1.0	
chanc alcl 0.8533916849015317	
publishedin markedli 0.8533916849015317	
new chanc 0.8533916849015317	
live larg 0.8533916849015317	
percent discov 0.8533916849015317	
publishedin differenti 0.8533916849015317	
test discov 0.8533916849015317	
patient genet 1.0	
patient develop 1.0	
cell aid 0.8533916849015317	
chanc anaplast 0.8533916849015317	
new aid 0.8533916849015317	
test publishedin 0.8533916849015317	
type new 0.8533916849015317	
recommend hadtp 0.8533916849015317	
test chanc 0.8533916849015317	
evalu anaplast 1.0	
percent patient 0.8533916849015317	
type surviv 0.8533916849015317	
patient bymayo 0.8533916849015317	
tumor cell 1.0	
hodgkin chanc 0.8533916849015317	
team discov 0.8533916849015317	
singl rearrang 0.8533916849015317	
year recommend 0.8533916849015317	
subgroup publishedin 0.8533916849015317	
singl discov 0.8533916849015317	
research rearrang 0.8533916849015317	
publishedin live 0.8533916849015317	
team ofnon 0.8533916849015317	
ofnon markedli 0.8533916849015317	
lymphoma hodgkin 0.8533916849015317	
lymphomathat alk 0.8533916849015317	
tailor step 1.0	
rearrang patient 1.0	
haddusp aid 0.8533916849015317	
hadtp bymayo 0.8533916849015317	
tumor swap 1.0	
patient bymayo 0.8533916849015317	
neg larg 0.8533916849015317	
microscop individu 1.0	
lymphomathat larg 0.8533916849015317	
subgroup lymphomathat 0.8533916849015317	
step anaplast 1.0	
tumor chanc 0.8533916849015317	
patient fish 1.0	
patient alcl 0.8533916849015317	
clinic anaplast 0.8533916849015317	
test patient 1.0	
year pathologi 0.8533916849015317	
percent bymayo 0.8533916849015317	
publishedin chanc 0.8533916849015317	
networkamayo hadtp 0.8533916849015317	
percent hadtp 0.8533916849015317	
subgroup bymayo 0.8533916849015317	
larg cell 1.0	
rearrang compar 0.8533916849015317	
singl ofnon 0.8533916849015317	
subgroup pathologi 0.8533916849015317	
surviv markedli 0.8533916849015317	
singl patient 0.8533916849015317	
type patient 0.8533916849015317	
percent group 0.8533916849015317	
perform genet 1.0	
discov alk 0.8533916849015317	
recommend new 0.8533916849015317	
group differenti 0.8533916849015317	
lymphoma alcl 0.8533916849015317	
team clinic 0.8533916849015317	
patient lymphomathat 0.8533916849015317	
diagnosi anaplast 0.8533916849015317	
rearrang led 0.8533916849015317	
year rate 0.8533916849015317	
ofnon lymphomathat 0.8533916849015317	
tumor networkamayo 0.8533916849015317	
rearrang lymphomathat 0.8533916849015317	
test patient 0.8533916849015317	
neg clinic 0.8533916849015317	
tumor chromosom 1.0	
patient hodgkin 0.8533916849015317	
step lymphoma 1.0	
pathologi journalblood 0.8533916849015317	
year hodgkin 0.8533916849015317	
recommend rate 0.8533916849015317	
larg develop 1.0	
subgroup discov 0.8533916849015317	
singl bymayo 0.8533916849015317	
microscop call 1.0	
recommend patient 0.8533916849015317	
bymayo alk 0.8533916849015317	
team percent 0.8533916849015317	
type cell 0.8533916849015317	
clinic alk 0.8533916849015317	
lymphoma chanc 0.8533916849015317	
surviv anaplast 0.8533916849015317	
visual cell 1.0	
ofnon diagnosi 0.8533916849015317	
team live 0.8533916849015317	
rearrang arrang 1.0	
surviv alk 0.8533916849015317	
patient live 0.8533916849015317	
studi anddusp 1.0	
tumor fish 1.0	
differenti diagnosi 0.8533916849015317	
team larg 0.8533916849015317	
singl recommend 0.8533916849015317	
diagnosi alcl 0.8533916849015317	
step larg 1.0	
type hodgkin 0.8533916849015317	
ofnon anaplast 0.8533916849015317	
group discov 0.8533916849015317	
new discov 0.8533916849015317	
author abnorm 1.0	
subgroup patient 0.8533916849015317	
swap recommend 1.0	
diagnosi chanc 0.8533916849015317	
tumor fish 1.0	
rearrang haddusp 0.8533916849015317	
research alcl 0.8533916849015317	
group alcl 0.8533916849015317	
lymphoma genet 0.8533916849015317	
subgroup percent 0.8533916849015317	
subgroup hadtp 0.8533916849015317	
rearrang group 0.8533916849015317	
rearrang rate 0.8533916849015317	
routin recommend 0.8533916849015317	
haddusp compar 0.8533916849015317	
studi evalu 1.0	
pathologi networkamayo 0.8533916849015317	
disturb abnorm 1.0	
percent lymphoma 0.8533916849015317	
pathologi chanc 0.8533916849015317	
surviv cell 0.8533916849015317	
patient evalu 1.0	
swap evalu 1.0	
patient alcl 0.8533916849015317	
lymphomathat clinic 0.8533916849015317	
team lymphoma 0.8533916849015317	
singl patient 0.8533916849015317	
therapi cell 1.0	
larg anaplast 1.0	
pathologist microscop 1.0	
tp step 1.0	
hadtp alk 0.8533916849015317	
subgroup haddusp 0.8533916849015317	
diagnosi compar 0.8533916849015317	
visual chromosom 1.0	
perform chromosom 1.0	
team recommend 0.8533916849015317	
patient lymphoma 0.8533916849015317	
percent lymphoma 0.8533916849015317	
step patient 1.0	
singl percent 0.8533916849015317	
larg genet 0.8533916849015317	
haddusp genet 0.8533916849015317	
studi cell 1.0	
dna cell 1.0	
neg lymphoma 0.8533916849015317	
tailor call 1.0	
journalblood bymayo 0.8533916849015317	
step individu 1.0	
tumor team 0.8533916849015317	
subgroup rearrang 0.8533916849015317	
singl patient 0.8533916849015317	
dna anaplast 1.0	
type singl 0.8533916849015317	
patient journalblood 0.8533916849015317	
situhybrid anaplast 1.0	
journalblood diagnosi 0.8533916849015317	
standard disturb 1.0	
studi standard 1.0	
tumor rearrang 1.0	
findingsar cell 0.8533916849015317	
publishedin percent 0.8533916849015317	
new led 0.8533916849015317	
visual arrang 1.0	
subgroup bymayo 0.8533916849015317	
test patient 0.8533916849015317	
tp fish 1.0	
singl differenti 0.8533916849015317	
perform patient 1.0	
therapi standard 1.0	
patient live 0.8533916849015317	
patient lymphoma 0.8533916849015317	
patient ofnon 0.8533916849015317	
year networkamayo 0.8533916849015317	
individu identifi 1.0	
type discov 0.8533916849015317	
test swap 1.0	
subgroup chanc 0.8533916849015317	
singl haddusp 0.8533916849015317	
lymphoma abnorm 1.0	
patient pathologist 1.0	
test call 1.0	
routin differenti 0.8533916849015317	
tumor percent 0.8533916849015317	
perform abnorm 1.0	
chanc alk 0.8533916849015317	
tumor therapi 1.0	
hodgkin diagnosi 0.8533916849015317	
test alcl 0.8533916849015317	
markedli led 0.8533916849015317	
patient ofnon 0.8533916849015317	
pathologist identifi 1.0	
arrang anaplast 1.0	
clinic alcl 0.8533916849015317	
recommend patient 1.0	
call anddusp 1.0	
surviv compar 0.8533916849015317	
rearrang percent 0.8533916849015317	
pathologi cell 0.8533916849015317	
microscop larg 1.0	
publishedin discov 0.8533916849015317	
patient clinic 0.8533916849015317	
routin genet 0.8533916849015317	
publishedin genet 0.8533916849015317	
pathologist evalu 1.0	
compar chanc 0.8533916849015317	
patient lymphoma 0.8533916849015317	
standard fish 1.0	
subgroup networkamayo 0.8533916849015317	
discov clinic 0.8533916849015317	
situhybrid abnorm 1.0	
test cell 1.0	
year routin 0.8533916849015317	
cell author 1.0	
percent journalblood 0.8533916849015317	
hodgkin hadtp 0.8533916849015317	
research markedli 0.8533916849015317	
surviv discov 0.8533916849015317	
pathologi alk 0.8533916849015317	
test alk 0.8533916849015317	
fluorescencein arrang 1.0	
tp cell 1.0	
new alcl 0.8533916849015317	
larg differenti 0.8533916849015317	
singl networkamayo 0.8533916849015317	
rearrang differenti 0.8533916849015317	
percent chanc 0.8533916849015317	
test rate 0.8533916849015317	
research bymayo 0.8533916849015317	
percent group 0.8533916849015317	
team neg 0.8533916849015317	
larg bymayo 0.8533916849015317	
develop cell 1.0	
type led 0.8533916849015317	
routin findingsar 0.8533916849015317	
subgroup clinic 0.8533916849015317	
therapi situhybrid 1.0	
situhybrid pathologist 1.0	
percent alcl 0.8533916849015317	
genet cell 1.0	
publishedin diagnosi 0.8533916849015317	
type networkamayo 0.8533916849015317	
publishedin lymphoma 0.8533916849015317	
live alk 0.8533916849015317	
percent haddusp 0.8533916849015317	
publishedin larg 0.8533916849015317	
fish arrang 1.0	
markedli genet 0.8533916849015317	
diagnosi clinic 0.8533916849015317	
tumor recommend 1.0	
networkamayo alcl 0.8533916849015317	
new neg 0.8533916849015317	
surviv haddusp 0.8533916849015317	
test fish 1.0	
patient critic 1.0	
larg cell 1.0	
percent diagnosi 0.8533916849015317	
therapi arrang 1.0	
rearrang hodgkin 0.8533916849015317	
findingsar discov 0.8533916849015317	
type subgroup 0.8533916849015317	
findingsar clinic 0.8533916849015317	
visual cell 1.0	
lymphomathat diagnosi 0.8533916849015317	
markedli lymphomathat 0.8533916849015317	
team pathologi 0.8533916849015317	
team research 0.8533916849015317	
develop anddusp 1.0	
test dna 1.0	
tumor larg 1.0	
findingsar alcl 0.8533916849015317	
test neg 0.8533916849015317	
test cell 0.8533916849015317	
journalblood hodgkin 0.8533916849015317	
rearrang anaplast 0.8533916849015317	
author abnorm 1.0	
pathologi genet 0.8533916849015317	
subgroup patient 0.8533916849015317	
recommend genet 0.8533916849015317	
lymphomathat alcl 0.8533916849015317	
step author 1.0	
rearrang alcl 0.8533916849015317	
team subgroup 0.8533916849015317	
test tailor 1.0	
pathologist cell 1.0	
journalblood alcl 0.8533916849015317	
patient discov 0.8533916849015317	
microscop gene 1.0	
tumor pathologi 0.8533916849015317	
hadtp clinic 0.8533916849015317	
tumor anddusp 1.0	
type chanc 0.8533916849015317	
perform alk 1.0	
lymphoma bymayo 0.8533916849015317	
subgroup diagnosi 0.8533916849015317	
led alcl 0.8533916849015317	
neg led 0.8533916849015317	
hadtp genet 0.8533916849015317	
clinic alcl 0.8533916849015317	
patient aid 0.8533916849015317	
patient anaplast 0.8533916849015317	
tumor singl 0.8533916849015317	
rearrang led 0.8533916849015317	
test rearrang 0.8533916849015317	
recommend patient 0.8533916849015317	
lymphoma led 0.8533916849015317	
singl journalblood 0.8533916849015317	
gene abnorm 1.0	
test research 0.8533916849015317	
visual therapi 1.0	
year patient 0.8533916849015317	
cell bymayo 0.8533916849015317	
percent anaplast 0.8533916849015317	
chromosom arrang 1.0	
fluorescencein fish 1.0	
individu cell 1.0	
rearrang compar 0.8533916849015317	
neg discov 0.8533916849015317	
ofnon new 0.8533916849015317	
tumor arrang 1.0	
ofnon lymphoma 0.8533916849015317	
routin patient 0.8533916849015317	
diagnos call 1.0	
neg alcl 0.8533916849015317	
rearrang percent 0.8533916849015317	
year alk 0.8533916849015317	
lymphoma live 0.8533916849015317	
ofnon alk 0.8533916849015317	
recommend bymayo 0.8533916849015317	
type neg 0.8533916849015317	
surviv aid 0.8533916849015317	
patient gene 1.0	
therapi author 1.0	
pathologi compar 0.8533916849015317	
visual author 1.0	
research chanc 0.8533916849015317	
rearrang lymphoma 0.8533916849015317	
rate group 0.8533916849015317	
larg individu 1.0	
patient anddusp 1.0	
tumor alk 0.8533916849015317	
microscop abnorm 1.0	
surviv differenti 0.8533916849015317	
patient larg 1.0	
cell author 1.0	
ofnon differenti 0.8533916849015317	
diagnosi cell 0.8533916849015317	
live aid 0.8533916849015317	
routin lymphoma 0.8533916849015317	
patient new 0.8533916849015317	
studi cell 1.0	
rearrang clinic 0.8533916849015317	
hodgkin haddusp 0.8533916849015317	
lymphoma abnorm 1.0	
recommend abnorm 1.0	
alk abnorm 1.0	
disturb abnorm 1.0	
tp situhybrid 1.0	
new alk 0.8533916849015317	
patient larg 1.0	
perform develop 1.0	
therapi swap 1.0	
led aid 0.8533916849015317	
rearrang larg 1.0	
subgroup lymphoma 0.8533916849015317	
test hadtp 0.8533916849015317	
bymayo alcl 0.8533916849015317	
subgroup live 0.8533916849015317	
evalu chromosom 1.0	
publishedin pathologi 0.8533916849015317	
percent discov 0.8533916849015317	
subgroup lymphoma 0.8533916849015317	
genet arrang 1.0	
rearrang clinic 0.8533916849015317	
test author 1.0	
fish call 1.0	
journalblood clinic 0.8533916849015317	
test surviv 0.8533916849015317	
step critic 1.0	
rearrang alk 0.8533916849015317	
recommend exampl 1.0	
tailor evalu 1.0	
genet gene 1.0	
genet discov 0.8533916849015317	
recommend alcl 0.8533916849015317	
networkamayo chanc 0.8533916849015317	
visual larg 1.0	
test patient 0.8533916849015317	
lymphoma hadtp 0.8533916849015317	
lymphoma anddusp 1.0	
subgroup alk 0.8533916849015317	
cell anddusp 1.0	
recommend clinic 0.8533916849015317	
pathologist larg 1.0	
compar bymayo 0.8533916849015317	
singl publishedin 0.8533916849015317	
test pathologist 1.0	
markedli clinic 0.8533916849015317	
lymphoma journalblood 0.8533916849015317	
hodgkin compar 0.8533916849015317	
swap studi 1.0	
neg live 0.8533916849015317	
rearrang hodgkin 0.8533916849015317	
chromosom abnorm 1.0	
patient neg 0.8533916849015317	
tp neg 1.0	
tailor larg 1.0	
test cell 1.0	
perform anaplast 1.0	
patient hodgkin 0.8533916849015317	
differenti chanc 0.8533916849015317	
singl larg 0.8533916849015317	
tailor perform 1.0	
larg abnorm 1.0	
ofnon group 0.8533916849015317	
patient genet 0.8533916849015317	
differenti anaplast 0.8533916849015317	
recommend discov 0.8533916849015317	
larg alk 0.8533916849015317	
team chanc 0.8533916849015317	
studi recommend 1.0	
subgroup recommend 0.8533916849015317	
therapi evalu 1.0	
situhybrid alk 1.0	
larg aid 0.8533916849015317	
markedli chanc 0.8533916849015317	
develop arrang 1.0	
swap individu 1.0	
pathologi findingsar 0.8533916849015317	
rate percent 0.8533916849015317	
neg hodgkin 0.8533916849015317	
neg compar 0.8533916849015317	
year hadtp 0.8533916849015317	
rearrang clinic 0.8533916849015317	
fish anaplast 1.0	
tumor test 1.0	
surviv routin 0.8533916849015317	
new markedli 0.8533916849015317	
diagnos cell 1.0	
perform lymphoma 1.0	
tumor abnorm 1.0	
year markedli 0.8533916849015317	
situhybrid individu 1.0	
subgroup neg 0.8533916849015317	
team percent 0.8533916849015317	
new haddusp 0.8533916849015317	
percent patient 0.8533916849015317	
pathologi anaplast 0.8533916849015317	
lymphoma group 0.8533916849015317	
publishedin haddusp 0.8533916849015317	
subgroup percent 0.8533916849015317	
patient compar 0.8533916849015317	
disturb develop 1.0	
visual exampl 1.0	
haddusp findingsar 0.8533916849015317	
exampl disturb 1.0	
exampl dna 1.0	
publishedin lymphomathat 0.8533916849015317	
rate clinic 0.8533916849015317	
research compar 0.8533916849015317	
test step 1.0	
pathologi lymphoma 0.8533916849015317	
led group 0.8533916849015317	
fluorescencein develop 1.0	
lymphoma haddusp 0.8533916849015317	
tumor perform 1.0	
research led 0.8533916849015317	
anaplast aid 0.8533916849015317	
publishedin compar 0.8533916849015317	
subgroup findingsar 0.8533916849015317	
findingsar differenti 0.8533916849015317	
team group 0.8533916849015317	
neg disturb 1.0	
subgroup clinic 0.8533916849015317	
swap chromosom 1.0	
rate publishedin 0.8533916849015317	
routin bymayo 0.8533916849015317	
test alk 1.0	
individu evalu 1.0	
hodgkin differenti 0.8533916849015317	
tumor anddusp 1.0	
surviv rate 0.8533916849015317	
discov anaplast 0.8533916849015317	
pathologi led 0.8533916849015317	
clinic aid 0.8533916849015317	
percent findingsar 0.8533916849015317	
patient haddusp 0.8533916849015317	
neg genet 0.8533916849015317	
team alk 0.8533916849015317	
rearrang anddusp 1.0	
journalblood anaplast 0.8533916849015317	
lymphoma cell 0.8533916849015317	
subgroup markedli 0.8533916849015317	
tumor disturb 1.0	
tumor subgroup 0.8533916849015317	
patient exampl 1.0	
led discov 0.8533916849015317	
hodgkin findingsar 0.8533916849015317	
type routin 0.8533916849015317	
percent pathologi 0.8533916849015317	
routin clinic 0.8533916849015317	
tumor individu 1.0	
larg group 0.8533916849015317	
fish diagnos 1.0	
differenti alk 0.8533916849015317	
publishedin aid 0.8533916849015317	
pathologist fluorescencein 1.0	
tailor diagnos 1.0	
team cell 0.8533916849015317	
tumor develop 1.0	
therapi patient 1.0	
percent neg 0.8533916849015317	
journalblood discov 0.8533916849015317	
singl compar 0.8533916849015317	
team led 0.8533916849015317	
individu develop 1.0	
disturb alk 1.0	
ofnon bymayo 0.8533916849015317	
step patient 1.0	
percent larg 0.8533916849015317	
percent alk 0.8533916849015317	
perform larg 1.0	
test genet 0.8533916849015317	
type pathologi 0.8533916849015317	
patient cell 0.8533916849015317	
findingsar diagnosi 0.8533916849015317	
lymphoma arrang 1.0	
subgroup clinic 0.8533916849015317	
recommend patient 1.0	
live clinic 0.8533916849015317	
patient live 0.8533916849015317	
subgroup lymphomathat 0.8533916849015317	
microscop exampl 1.0	
routin rate 0.8533916849015317	
recommend chanc 0.8533916849015317	
cell alcl 0.8533916849015317	
test group 0.8533916849015317	
markedli lymphoma 0.8533916849015317	
group bymayo 0.8533916849015317	
differenti compar 0.8533916849015317	
rearrang haddusp 0.8533916849015317	
year ofnon 0.8533916849015317	
lymphoma anaplast 0.8533916849015317	
rearrang cell 1.0	
surviv research 0.8533916849015317	
tp evalu 1.0	
percent anaplast 0.8533916849015317	
identifi chromosom 1.0	
subgroup patient 0.8533916849015317	
lymphoma diagnosi 0.8533916849015317	
tumor haddusp 0.8533916849015317	
lymphoma clinic 0.8533916849015317	
chanc aid 0.8533916849015317	
surviv led 0.8533916849015317	
microscop alk 1.0	
rate findingsar 0.8533916849015317	
fluorescencein anddusp 1.0	
rate compar 0.8533916849015317	
subgroup rearrang 0.8533916849015317	
subgroup aid 0.8533916849015317	
perform arrang 1.0	
rate hodgkin 0.8533916849015317	
haddusp chanc 0.8533916849015317	
pathologi discov 0.8533916849015317	
discov bymayo 0.8533916849015317	
call alk 1.0	
hadtp anaplast 0.8533916849015317	
standard situhybrid 1.0	
subgroup percent 0.8533916849015317	
tumor recommend 0.8533916849015317	
pathologist alk 1.0	
group compar 0.8533916849015317	
lymphoma genet 1.0	
markedli live 0.8533916849015317	
lymphomathat group 0.8533916849015317	
ofnon aid 0.8533916849015317	
recommend larg 0.8533916849015317	
cell anddusp 1.0	
recommend markedli 0.8533916849015317	
haddusp bymayo 0.8533916849015317	
disturb cell 1.0	
lymphoma aid 0.8533916849015317	
recommend diagnos 1.0	
call author 1.0	
lymphoma cell 1.0	
patient develop 1.0	
tumor critic 1.0	
singl alk 0.8533916849015317	
hadtp compar 0.8533916849015317	
pathologi group 0.8533916849015317	
compar clinic 0.8533916849015317	
neg markedli 0.8533916849015317	
new lymphoma 0.8533916849015317	
identifi alk 1.0	
gene cell 1.0	
patient fish 1.0	
type research 0.8533916849015317	
subgroup led 0.8533916849015317	
perform exampl 1.0	
visual fish 1.0	
neg lymphoma 0.8533916849015317	
tailor disturb 1.0	
pathologi markedli 0.8533916849015317	
ofnon findingsar 0.8533916849015317	
larg anaplast 0.8533916849015317	
led bymayo 0.8533916849015317	
new clinic 0.8533916849015317	
publishedin alcl 0.8533916849015317	
live haddusp 0.8533916849015317	
neg identifi 1.0	
test abnorm 1.0	
tumor lymphoma 1.0	
surviv subgroup 0.8533916849015317	
test identifi 1.0	
haddusp cell 0.8533916849015317	
rearrang journalblood 0.8533916849015317	
patient diagnosi 0.8533916849015317	
genet alcl 0.8533916849015317	
lymphoma gene 1.0	
lymphomathat haddusp 0.8533916849015317	
hadtp haddusp 0.8533916849015317	
routin new 0.8533916849015317	
markedli clinic 0.8533916849015317	
chromosom call 1.0	
hadtp diagnosi 0.8533916849015317	
percent cell 0.8533916849015317	
tumor rate 0.8533916849015317	
rearrang hadtp 0.8533916849015317	
rearrang neg 0.8533916849015317	
type ofnon 0.8533916849015317	
test differenti 0.8533916849015317	
type findingsar 0.8533916849015317	